*Oropouche virus* (OROV), the cause of Oropouche fever, belongs to the family *Bunyaviridae*, genus *Orthobunyavirus,* Simbu serogroup ([@R1]), and is transmitted between humans in urban areas by the biting midge *Culicoides paraensis* ([@R2],[@R3]). This virus was first isolated from febrile forest workers in Trinidad in 1955. The first isolation in Brazil was in 1960 from the blood of a sloth (*Bradypus tridactylus*) ([@R4]). The epidemic potential of OROV was recognized during an outbreak in Belém, Pará State, Brazil, in 1961, where ≈11,000 persons were infected ([@R4]). Over the past 45 years, many outbreaks of Oropouche fever, ≈500,000 cases, have been described in the Americas. OROV has been isolated in Trinidad, Panama, Peru, and Brazil, and in the past 40 years Oropouche fever has emerged as a public health problem in tropical areas of Central and South America ([@R3]).

Members of the genus *Orthobunyavirus* have a tripartite, single-stranded, negative-sense RNA genome of small (S), medium (M), and large (L) RNAs that encode nucleocapsid, glycoproteins, and RNA polymerase, respectively. Phylogenetic analysis of nucleocapsid genes of different OROV strains identified 3 distinct genotypes (I, II, and III) currently circulating in Central and South America; genotypes I and II have been detected in the Brazilian Amazon ([@R5]). Recently, an OROV isolate from a marmoset (*Callithrix* sp.) was characterized as a member of genotype III ([@R6]).

The Study
=========

Two outbreaks of Oropuche fever occurred during 2003 and 2004. The first occurred in April--May 2003 in 2 communities (Vila Sansão, 140 inhabitants, and Vila Paulo Fontelles, 835 inhabitants).in the municipality of Parauapebas (6°4′S, 49°54′W). The second outbreak occurred in July--August 2004 in 1 community (Vila Tapara, 2,000 inhabitants) in the municipality of Porto de Moz (1°45′S, 52°14′W) ([Figure 1](#F1){ref-type="fig"}).
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A total of 125 and 109 serum samples were collected from residents of Parauapebas and Porto de Moz, which represented 12.8% and 5.45% of all inhabitants, respectively. Criteria for sampling were a history of acute fever several weeks before or during the survey or clinical symptoms similar to those of Oropouche fever. All serum samples were analyzed by hemagglutination inhibition (HI) test ([@R7]) and immunoglobulin M--ELISA ([@R8]) for specific HI and IgM antibodies to OROV. HI titers [\>]{.ul}20 and ELISA results greater than the cut-off value (optical density [\>]{.ul}0.200) were considered positive ([@R8]).Virus isolation was conducted by intracranial injection of newborn mice with a 1:10 (v/v) suspension of serum samples in phosphate-buffered saline, pH 7.4, as described elsewhere ([@R9]). Fifty-four and 11 serum samples from Parauapebas and Porto de Moz, respectively, were used for virus isolation. Identification of isolates was performed by complement fixation test as reported ([@R9]). Two OROV strains were isolated from patients in Parauapebas, and 2 strains were isolated from patients in Porto de Moz.

To genetically characterize the viruses, 2 isolates were selected from Parauapebas (Brazil 2003a and Brazil 2003b) and 2 from Porto de Moz (Brazil 2004a and Brazil 2004b). Viral RNA was extracted from Vero cells infected with human samples, and S RNA was amplified by using a 1-step reverse transcription--PCR assay as described ([@R5]*,*[@R6]). Phylogenetic trees were constructed for nucleocapsid gene nucleotide sequences by comparison with other OROV nucleocapsid gene sequences in GenBank ([Table 1](#T1){ref-type="table"}); neighbor-joining analysis ([@R10]) implemented in Mega version 2.1 ([@R11]) was used. Bootstrap analyses were performed on 1,000 replicates to generate confidence for groupings ([@R12]).

###### Characteristics of *Oropouche virus* strains used for small RNA phylogenetic analyses

  Strain        Source                   Sample    Year   Location                     GenBank strain identification   Accession no.
  ------------- ------------------------ --------- ------ ---------------------------- ------------------------------- ---------------
  TRVL 9760     Human                    Blood     1955   Trinidad                     Trinidad 55                     AF164531
  BeAn 19991    *Bradypus trydactylus*   Blood     1960   São Miguel, Brazil           Brazil 60                       AF164532
  BeH 271815    Human                    Blood     1975   Santarém, Brazil             Brazil 75                       AF164533
  BeAn 206119   *Bradypus trydactylus*   Blood     1971   Maracanã, Brazil             Brazil 71a                      AY993909
  BeAn 208402   *Bradypus trydactylus*   Blood     1971   Maracanã, Brazil             Brazil 71b                      AY993910
  BeAn 208819   *Bradypus trydactylus*   Blood     1971   Maracanã, Brazil             Brazil 71c                      AY993911
  BeAn 208823   *Bradypus trydactylus*   Blood     1971   Maracanã, Brazil             Brazil 71d                      AY993912
  BeH 390233    Human                    Blood     1980   Manaus, Brazil               Brazil 80c                      AF164536
  BeH 381114    Human                    Blood     1980   Belém, Brazil                Brazil 80b                      AF164535
  BeH 379693    Human                    Blood     1980   Castanhal, Brazil            Brazil 80a                      AF164534
  BeH 472200    Human                    Blood     1988   Porto Franco, Brazil         Brazil 88a                      AF164537
  BeH 472204    Human                    Blood     1988   Tocantinópolis, Brazil       Brazil 88b                      AF164538
  BeAr 473358   *Culicoides paraensis*   Pool      1988   Porto Franco, Brazil         Brazil 88c                      AF164539
  BeH 475248    Human                    Blood     1988   Tucuruí, Brazil              Brazil 88d                      AF164540
  GLM 444477    Human                    Blood     1989   Panama                       Panama 89a                      AF164555
  GLM 444911    Human                    Blood     1989   Panama                       Panama 89b                      AF164556
  GLM 445252    Human                    Blood     1989   Panama                       Panama 89c                      AF164557
  GLM 450093    Human                    Blood     1989   Panama                       Panama 89d                      AF164558
  BeH 505514    Human                    Blood     1991   Santa Isabel, Brazil         Brazil 91a                      AF164541
  BeH 505442    Human                    Blood     1991   Ouro Preto d'Oeste, Brazil   Brazil 91b                      AF164542
  BeH 505663    Human                    Blood     1991   Ariquemes, Brazil            Brazil 91c                      AF164543
  IQT 1690      Human                    Blood     1992   Peru                         Peru 92                         AF164549
  MD 023        Human                    Blood     1993   Peru                         Peru 93a                        AF164550
  DEI 209       Human                    Blood     1993   Peru                         Peru 93b                        AF164551
  BeH 521086    Human                    Serum     1993   Barra do Corda, Brazil       Brazil 93                       AY704559
  BeH 541863    Human                    Blood     1996   Altamira, Brazil             Brazil 96a                      AF164544
  BeH 543033    Human                    Blood     1996   Oriximiná, Brazil            Brazil 96b                      AF164545
  BeH 544552    Human                    Blood     1996   Brasil Novo, Brazil          Brazil 96c                      AF164546
  BeH 543087    Human                    Blood     1996   Xapuri, Brazil               Brazil 96d                      AF164547
  BeH 543618    Human                    Blood     1996   Oriximiná, Brazil            Brazil 96e                      AF164548
  BeH 543733    Human                    Serum     1996   Oriximiná, Brazil            Brazil 96f                      AY704560
  IQT 4083      Human                    Blood     1997   Peru                         Peru 97                         AF164552
  01--812--98   Human                    Blood     1998   Peru                         Peru 98a                        AF164553
  IQT 7085      Human                    Blood     1998   Peru                         Peru 98b                        AF164554
  BeAn 626990   *Callithrix sp*.         Viscera   2000   Arinos, Brazil               Brazil 00                       AY117135
  BeH 622544    Human                    Blood     2002   Paranã, Brazil               Brazil 02                       EF467368
  BeH 669314    Human                    Blood     2003   Parauapebas, Brazil          Brazil 03a                      EF467370
  Be H 669315   Human                    Blood     2003   Parauapebas, Brazil          Brazil 03b                      EF467369
  BeH 682426    Human                    Blood     2004   Porto de Moz, Brazil         Brazil 04a                      EF467377
  BeH 682431    Human                    Blood     2004   Porto de Moz, Brazil         Brazil 04b                      EF467372

Of 125 serum samples from patients in Parauapebas, HI results were positive for 16 (12.7%) from Vila Sansão, 6 (4.8%) from Paulo Fontelles, and 4 (3.2%) from other localities. IgM was detected in 16 (12.7%), 8 (4.8%), and 6 (4.8%) serum samples from these 3 areas, respectively. Of 117 serum samples from patients in Porto de Moz, 56 (46.7%) had HI antibodies and 61 (52.1%) had IgM to OROV.

A total of 71.9% of female patients in Parauapebas and 59% in Porto de Moz had symptoms suggestive of Oropouche fever. Although all age groups were affected, persons 5--14 years of age had the highest frequency of symptoms (30.4%) and those \<1--4 years of age had the lowest frequency (4.8%) ([Table 2](#T2){ref-type="table"}). Symptoms most frequently reported were fever (100%), headache (79.3%), joint pain (68.7%), and muscle pain (30%). Seventy percent of patients reported ≥1 episode of recurrence of fever, characterized by fever, headache, and other symptoms ≈2--3 weeks after onset of initial symptoms ([@R2],[@R3]).

###### Distribution of serum samples positive for immunoglobulin M to *Oropouche virus* in 2 municipalities, Pará State, Brazil, 2003--2004

  Patient age, y   Porto de Moz, no. positive/no. tested   Parauapebas, no. positive/no. tested          
  ---------------- --------------------------------------- -------------------------------------- ------ -------
  \<1--4           1/6                                     3/4                                    0/2    1/9
  5--14            11/21                                   7/19                                   3/21   7/24
  15--24           2/7                                     7/14                                   0/4    4/13
  25--34           4/7                                     6/10                                   0/3    5/11
  35--44           4/5                                     3/5                                    4/4    1/7
  45--54           2/3                                     4/8                                    1/7    3/8
  ≥55              2/3                                     5/5                                    1/6    2/5
  Total            26/52                                   35/65                                  9/47   23/77

Full-length S RNA of the 4 OROV strains contained 754 nt and encoded 2 overlapping open reading frames, the nucleocapsid (693 nt and 231 aa) and nonstructural protein (273 nt and 91 aa). Two small noncoding regions were also found at the 3′ and 5′ ends of these reading frames, spanning nt positions 1--44 and 741--754, respectively. Phylogenetic analysis of Brazil 2003 and 2004 isolates grouped strains from Parauapebas (Brazil 2003a and Brazil 2003b) into OROV genotype I and strains from Porto de Moz (Brazil 2004a and Brazil 2004b) into OROV genotype II ([Figure 2](#F2){ref-type="fig"}).
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Conclusions
===========

Oropouche fever is the second most common arboviral disease (after dengue fever) in the Brazilian Amazon region. From 1960 to 1980, Oropouche fever outbreaks were detected only in Pará State, mainly in Belém and neighboring areas, where thousands of people were infected ([@R2],[@R3]). OROV was then detected in other Amazonian states including Amazonas, Amapá, Acre, Rondônia, and Tocantins; and non-Amazonian states, including Maranhão in northeastern Brazil and Tocantins in central Brazil ([@R3],[@R8]). Recently, OROV isolated from *Callithrix* sp.in Arinos, Minas Gerais State, southeastern Brazil was characterized as genotype III, which indicated the presence of this genotype in Brazil ([@R6]). OROV from this species has been identified only in Panama ([@R5]). From 1980 to 2005, sporadic cases or self-limited outbreaks of Oropouche fever were reported in areas of the Brazilian Amazon, which suggested silent endemic circulation of the virus ([@R13]). In 2003 and 2004, several cases of Oropouche fever were detected in Parauaebas and Porto de Moz in Pará State. Parauaebas is located in the Carajás mineral province and Porto de Moz is located in the Altamira region.

Genetic characterization of strains indicated the presence of genotype II in the eastern Amazon region. This genotype had been associated with cases of Oropouche fever in restricted western Amazonian areas (Rondônia State), as well as in Peru ([@R5]). This finding suggests movement of OROV genotype II across the Amazon region from western to eastern areas or emergence of this genotype after silent circulation for several years. Genotype I (Brazil 2003a and Brazil 2003b) found in Parauapebas was closely related to Trinidadian and Brazilian isolates obtained from 1955 through 1960 (Trinidad 55 and Brazil 60) ([@R5]). Genotype II strains isolated in Porto de Moz were genetically related to strains isolated in Peru during the 1990s (Peru 92, 93, 97, 98a, 98b) and Rondônia State in 1991 (Brazil 91a, 91b), as reported by Saeed et al. ([@R5]). These data indicate that Parauapebas and Porto de Moz OROV isolates are genetically distinct and have different ancestor viruses ([Figure 2](#F2){ref-type="fig"}). Recognition of different OROV genotypes in the Brazilian Amazon, as well as new genetic information, is useful for understanding the epidemiology and genetic diversity of this emergent human pathogen.
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